Valuation: Abbott Laboratories

Market Cap 155B 136B 125B 115B 218B 14,962B 222B 1,497B 587B 7,313B 584B 571B 25,206B P/E 2026 *
22.3x
P/E 2027 * 19.1x
Enterprise Value 164B 143B 132B 121B 230B 15,738B 234B 1,575B 618B 7,692B 614B 601B 26,513B EV / Sales 2026 *
3.25x
EV / Sales 2027 * 2.94x
Free-Float
86.73%
Yield 2026 *
2.86%
Yield 2027 * 3.05%
1 day+17.28%
3 months-24.71%
6 months-30.19%
Current year-30.19%
Current year 72.68
Extreme 72.68
98.39
1 year 72.68
Extreme 72.68
98.39
3 years 72.68
Extreme 72.68
110.91
5 years 72.68
Extreme 72.68
110.91
10 years 72.68
Extreme 72.68
110.91
Manager TitleAgeSince
Chief Executive Officer 52 2020-03-30
Director of Finance/CFO 53 2023-08-31
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 2011-12-08
Director/Board Member 67 2011-12-08
Director/Board Member 71 2017-02-15
Change 5-day change 1-year change 3-year change Capi.($)
+17.21%0.00% - - 155B
+4.08%+2.04%-6.36%-3.04% 103B
+2.11%+0.15%+1.70%+57.65% 57.7B
-1.11%+4.77%+38.09%+52.37% 52.27B
+2.54%+5.34%-10.87%-38.08% 42.68B
+3.03%-0.64% - - 33.35B
+6.83%+7.35%-6.82%-42.97% 28.06B
+1.00%+1.66%+62.04%-5.22% 25.36B
-1.11%+4.01%-3.88%-18.46% 21.03B
+2.60%+0.75%-4.40%-4.70% 20.61B
Average +3.75%+1.02%+8.69%-0.31% 42.67B
Weighted average by Cap. +6.74%+0.25%+6.22%+6.56%

Financials

2026 *2027 *
Net sales 50.26B 43.94B 40.54B 37.26B 70.61B 4,836B 71.81B 484B 190B 2,364B 189B 185B 8,148B 54.74B 47.86B 44.15B 40.58B 76.9B 5,267B 78.21B 527B 207B 2,574B 206B 201B 8,873B
Net income 6.92B 6.05B 5.58B 5.13B 9.73B 666B 9.89B 66.66B 26.16B 326B 26B 25.43B 1,122B 8.28B 7.24B 6.68B 6.14B 11.64B 797B 11.84B 79.77B 31.3B 390B 31.11B 30.43B 1,343B
Net Debt 8.07B 7.05B 6.51B 5.98B 11.33B 776B 11.53B 77.69B 30.48B 379B 30.3B 29.64B 1,308B 5.45B 4.77B 4.4B 4.04B 7.66B 525B 7.79B 52.52B 20.61B 257B 20.49B 20.04B 884B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
89.27USD
Average target price
116.54USD
Spread / Average Target
+30.55%

Quarterly revenue - Rate of surprise